SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
ENTERPRISE PARTNERS VI LP

(Last) (First) (Middle)
C/O ENTERPRISE PARTNERS
2223 AVENIDA DE LA PLAYA, SUITE 300

(Street)
LA JOLLA CA 92037-3218

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
COMPLETE GENOMICS INC [ GNOM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
11/16/2010
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, par value $0.001 11/16/2010 C 315,746 A (1) 315,746 D(2)
Common Stock, par value $0.001 11/16/2010 C 257,677 A (3) 573,423 D(2)
Common Stock, par value $0.001 11/16/2010 C 177,084 A (4) 750,507 D(2)
Common Stock, par value $0.001 11/16/2010 C 488,789 A (5) 1,239,296 D(2)
Common Stock, par value $0.001 11/16/2010 C 547,094 A (5) 1,786,390 D(2)
Common Stock, par value $0.001 11/16/2010 X 308,930 A $1.5 2,095,320 D(2)
Common Stock, par value $0.001 11/16/2010 F 51,489 D $9 2,043,831 D(2)
Common Stock, par value $0.001 11/16/2010 X 32,364 A $7.56 2,076,195 D(2)
Common Stock, par value $0.001 11/16/2010 F 27,186 D $9 2,049,009 D(2)
Common Stock, par value $0.001 11/16/2010 X 17,261 A $7.56 2,066,270 D(2)
Common Stock, par value $0.001 11/16/2010 F 14,500 D $9 2,051,770 D(2)
Common Stock, par value $0.001 11/16/2010 X 2,958 A $7.56 2,054,728 D(2)
Common Stock, par value $0.001 11/16/2010 F 2,485 D $9 2,052,243 D(2)
Common Stock, par value $0.001 11/16/2010 X 1,096 A $7.56 2,053,339 D(2)
Common Stock, par value $0.001 11/16/2010 F 921 D $9 2,052,418 D(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Series A Preferred Stock(1) (1) 11/16/2010 C 315,746 (6) (7) Common Stock 315,746 (1) 0 D(2)
Series B Preferred Stock(3) (3) 11/16/2010 C 257,677 (6) (7) Common Stock 257,677 (3) 0 D(2)
Series C Preferred Stock(4) (4) 11/16/2010 C 177,084 (6) (7) Common Stock 177,084 (4) 0 D(2)
Series D Preferred Stock(5) (5) 11/16/2010 C 488,789 (6) (7) Common Stock 488,789 (5) 0 D(2)
Series E Preferred Stock(5) (5) 11/16/2010 C 547,094 (6) (7) Common Stock 547,094 (5) 0 D(2)
Warrant to Purchase Common Stock $1.5 11/16/2010 X 308,930 (8) 08/12/2016 Common Stock 308,930 $0 0 D(2)
Warrant to Purchase Series B Preferred Stock(3) $11.642(9) 11/16/2010 J(10) 924 (8) 02/21/2012 Common Stock 924 $0 0 D(2)
Warrant to Purchase Series B Preferred Stock(3) $11.642(9) 11/16/2010 J(10) 242 (8) 03/12/2012 Common Stock 242 $0 0 D(2)
Warrant to Purchase Series D Preferred Stock(5) $7.56 11/16/2010 X 32,364 (8) 02/13/2014 Common Stock 32,364 $0 0 D(2)
Warrant to Purchase Series D Preferred Stock(5) $7.56 11/16/2010 X 17,261 (8) 04/06/2014 Common Stock 17,261 $0 0 D(2)
Warrant to Purchase Series D Preferred Stock(5) $7.56 11/16/2010 X 2,958 (8) 06/12/2014 Common Stock 2,958 $0 0 D(2)
Warrant to Purchase Series D Preferred Stock(5) $7.56 11/16/2010 X 1,096 (8) 08/05/2014 Common Stock 1,096 $0 0 D(2)
Explanation of Responses:
1. Each share of Series A Preferred Stock was automatically converted into common stock immediately prior to the completion of the Issuer's initial public offering. Shares are reported on an "as converted" basis giving effect to the 4.615101 conversion ratio applicable to such shares.
2. The shares are owned by Enterprise Partners VI, LP ("Enterprise VI"). Enterprise Management Partners VI, LLC ("Enterprise VI LLC") serves as the general partner of Enterprise VI. Andrew E. Senyei, M.D. is a managing director of Enterprise VI LLC and shares voting and investment power over the shares held by Enterprise VI.
3. Each share of Series B Preferred Stock was automatically converted into common stock immediately prior to the completion of the Issuer's initial public offering. Shares are reported on an "as converted" basis giving effect to the 5.926613 conversion ratio applicable to such shares.
4. Each share of Series C Preferred Stock was automatically converted into common stock immediately prior to the completion of the Issuer's initial public offering. Shares are reported on an "as converted" basis giving effect to the 8.241076 conversion ratio applicable to such shares.
5. Each share of Series D and Series E Preferred Stock was automatically converted into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering.
6. The securities are immediately convertible.
7. The expiration date is not relevant to the conversion of these securities.
8. The warrant is immediately exercisable.
9. The Exercise Price of the Warrant to Purchase Series B Preferred Stock is $69.00 per share of Series B Preferred Stock. The exercise price is reported on an "as converted" basis after giving effect to the 5.926613 conversion ratio.
10. Warrant canceled pursuant to its terms concurrent with closing of Issuer's initial public offering.
/s/ Andrew E. Senyei, Managing Director, Enterprise Partners VI, L.P. 11/16/2010
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.